Stocktoria

HUTCHMED (China) Ltd HCM

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2006-05-19

HUTCHMED (China) Ltd statistics & valuation

Market cap$14.3B
P / E31.3×
P / S26.1×
P / B11.4×
Net margin83.3%
Return on equity36.5%
FCF margin-14.4%
Net debt$21.8M
Enterprise value USD$14.3B
Earnings yield EBIT/EV-0.3%
Return on capital-2.7%
Graham number -66.6%$4.10

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($4.10); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
5.40% -11.10% -34.90% -51.70% -55.20% -54.70% -84.60% 12.00% 6.00% 83.30% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-21.60% -22.10% -43.30% -71.40% -86.30% -92.20% -95.60% 2.20% -6.90% -7.10% 2016201720182019202020212022202320242025
Return on equity (%)
5.70% -5.50% -18.20% -33.90% -24.20% -18.70% -56.70% 13.60% 4.90% 36.50% 2016201720182019202020212022202320242025
Shares outstanding
607.1M 617.2M 664.3M 666.9M 727.7M 864.5M 864.8M 871.3M 872.8M 872.9M 2016201720182019202020212022202320242025
Net debt ($)
-$32.6M -$55.3M -$59.3M -$94.3M -$208.8M -$295.2M -$204.2M -$71.2M $21.8M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
3.40% -4.50% -14.10% -22.80% -17.40% -14.20% -35.10% 7.90% 3.00% 26.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-6.40% -5.80% -18.30% -43.70% -30.70% -62.00% -71.60% 22.30% -2.80% -14.40% 2016201720182019202020212022202320242025
Debt / equity (×)
0.23× 0.06× 0.06× 0.09× 0.05× 0.03× 0.11× 0.11× 0.07× 2016201720182019202020212022202320242025
EPS ($)
$0.02 -$0.43 -$1.13 -$0.16 -$0.18 -$0.25 -$0.43 $0.12 $0.04 $0.52 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

HUTCHMED (China) Ltd trades at about 23.6× earnings — below its 10-year norm (10-year range 28.8×–704.5×, median 338×).

23.6× 704.5×

Shaded band = 10-year range (28.8×–704.5×); dot = today's 23.6×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-7.1%-6.9%2.2%-95.6%-92.2%-86.3%-71.4%-43.3%-22.1%-21.6%
Net margin83.3%6.0%12.0%-84.6%-54.7%-55.2%-51.7%-34.9%-11.1%5.4%
FCF margin-14.4%-2.8%22.3%-71.6%-62.0%-30.7%-43.7%-18.3%-5.8%-6.4%
Return on assets26.1%3.0%7.9%-35.1%-14.2%-17.4%-22.8%-14.1%-4.5%3.4%
Return on equity36.5%4.9%13.6%-56.7%-18.7%-24.2%-33.9%-18.2%-5.5%5.7%
Debt / equity0.07×0.11×0.11×0.03×—0.05×0.09×0.06×0.06×0.23×
Current ratio4.962.832.722.373.893.352.804.334.131.76

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.